PORTAIL DOCUMENTAIRE

Article

Population-based study of risk of breast cancer in carriers of BRCA2 mutation.

S. THORLACIUS ; J.E. EYFJORD ; P. HARTGE ; G.H. OLAFSDOTTIR ; H. SIGVALDASON ; J.P. STRUEWING ; L. TRYGGVADOTTIR ; H. TULINIUS ; S. WACHOLDER ; Division of Cancer Epidemlology and Genetics. National Cancer Institute. National Institute of Health. Bethesda MD. USA ; Icelandic Cancer Registry. Icelandic Cancer Society. Reykjavik. ISL ; Molecular and Cell Biology Research Laboratory. Icelandic Cancer Society. Reykjavik. ISL |

Dans Lancet (The) (vol. 352, n° 9137, 1998)

[BDSP. Notice produite par INIST 6UmNR0xg. Diffusion soumise à autorisation]. Background Estimates of an 80-90% risk of breast cancer for carriers of germline mutations in the BRCA1 and BRCA2 genes are based on studies of families at high risk o[...]

Plus d'information...

Ajouter à ma sélection